About Carpere Capital Management
Carpere Capital Management is a venture capital firm founded in 2019. It is primarily based out of Richmond, Canada. As of Feb 2020, Carpere Capital Management has invested in 16 companies. It primarily invests in Series A round in Canada based startups. Its investments are spread across a wide range of sectors from Food and Agriculture Tech to High Tech and Environment Tech. Most recently it participated in the $***** Series A round of NovoBind Livestock Therapeutics Overall, Carpere Capital Management portfolio has seen 6 IPOs and 3 acquisitions including key companies like Appili Therapeutics, Pond Technologies and Nemaska Lithium. A lot of funds co-invest with Carpere Capital Management, with names like Lallemand sharing a substantial percentage of its portfolio. Carpere Capital Management has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Rounds of Entry
Series A
Portfolio Acquisitions
Carpere Capital Management's List of Top Investments
Carpere Capital Management has a portfolio of 16 companies. Their most notable investmentis in NovoBind Livestock TherapeuticsTheir portfolio spans across Canada, Portugal and United States. They have invested in Food and Agriculture Tech, High Tech, Environment Tech and 14 other sectors, across stages such as Series A stage. Here is the list of top investments by Carpere Capital Management:Developer of drugs to treat infectious diseases. The company's product API-1503 is a class of 30S ribosome targeting agents for Gram-negative bacterias, API-1501 is a formulation of metronidazole, TI-2307 is a broad spectrum anti-fungal, ATI-1701 is a Tularemia vaccine, and Avigan is a broad-spectrum antiviral and therapeutic for COVID-19.
Key facts about Appili Therapeutics
- Founded Year: 2015
- Location: Halifax (Canada)
- Stage: Acquired
- Total Funding till date: $15.5M
- Employee Count: 18 as on May 31, 2026
- Investors: The Lind Partners, Fujifilm and 7 Others
- Latest Funding Round: Grant (prize money), Dec 05, 2025, $*****
- Highlight: Acquired
Developer of bioengineering technology for agriculture, food, health, and industrial markets. It creates products and solutions using whole organism and gene-targeted engineering. The technology benefits multiple industries, including biopesticides, animal wellness, bakery, coffee, alcoholic beverages, probiotics, nutritional supplements, flavors, fragrances, and biofuels.
Key facts about Renaissance BioScience
- Founded Year: 2013
- Location: Vancouver (Canada)
- Stage: Series A
- Total Funding till date: $5M
- Employee Count: 25 as on May 31, 2026
- Investors: Northview LifeSciences, Carpere Capital Management and 2 Others
- Latest Funding Round: Grant (prize money), Feb 09, 2024, $*****
- Highlight: Editors' Pick
Provider of algal biomass solutions. It converts raw smokestack emissions from heavy industry into algal biomass and utilizes the microalgae to convert the CO2 emissions of industrial emitters into biofuel.
Key facts about Pond Technologies
- Founded Year: 2008
- Location: Markham (Canada)
- Stage: Public
- Total Funding till date: $3.49M
- Employee Count: 8 as on May 31, 2026
- Investors: Canadian Space Agency, Carpere Capital Management and 5 Others
- Latest Funding Round: Post IPO, Mar 28, 2023, $*****
- Highlight: Public
4. AppCoins
The AppCoins project is developing a protocol for mobile advertising which enables increasing the volume and turnover of the mobile advertising market. The protocol is planned to be implemented as a cross-service solution, meaning any app store will be able to connect to the system and use its advantages to optimize its business. All transactions within the ecosystem will be conducted using the native token.
Key facts about AppCoins
- Founded Year: 2017
- Location: Lisbon (Portugal)
- Stage: Funding Raised
- Employee Count: 6 as on Jul 01, 2024
- Investors: Carpere Capital Management, Hash Capital and 1 Other
- Latest Funding Round: ICO, Dec 20, 2017, $*****
Key facts about Nemaska Lithium
- Founded Year: 2007
- Location: Montreal (Canada)
- Stage: Acquired
- Employee Count: 190 as on May 31, 2026
- Investors: Sustainable Development Technology Canada, Carpere Capital Management and 2 Others
- Latest Funding Round: Post IPO, May 23, 2018, $*****
- Highlight: Acquired
Carpere Capital Management's Year-on-Year Investment Trends
Its most recent first time investment was in NovoBind Livestock Therapeutics.Carpere Capital Management's Investments by Stage
Carpere Capital Management has made 1 investment in Series A stage.Carpere Capital Management's Investments by Sector
Carpere Capital Management has a portfolio focused on Food and Agriculture Tech. Notably, it has invested in 12 Enterprise (B2B) companies, 10 Tech companies, 2 Blockchain companies and at least 2 companies focusing on Software.Carpere Capital Management's Investments by Geography
Carpere Capital Management has made most investments in Canada (1).Carpere Capital Management's recent investments
Carpere Capital Management has not made any investment in 2026 so far.Here are the most recent investments by Carpere Capital Management:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 19, 2020 | Canada | Series A | 6550 | [+5] |
IPOs and Publicly Listed companies in Carpere Capital Management's Portfolio
6 of Carpere Capital Management's portfolio companies have become public. Invictus got listed on the Toronto Stock Exchange - Venture Exchange (TSX-V), in Mar 2017 and Sproutly got listed on the Canadian Securities Exchange (CSE) at marketcap of $75.8M.Here are Carpere Capital Management's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 31, 2017 | - | - | 2184 | |
Apr 21, 2016 | - | - | 9132 | |
Dec 20, 2012 | - | - | 7680 | |
Sep 25, 2012 | - | - | 4266 | |
Jan 07, 2000 | - | - | 3194 |
Acquired companies in Carpere Capital Management's Portfolio
3 companies from Carpere Capital Management's portfolio have been acquired. The most recent acquisition was Appili Therapeutics in Apr 2024 by Aditx Therapeutics for $*****.Here are Carpere Capital Management's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 02, 2024 | - | - | 1013 | |
Feb 09, 2024 | - | - | 7455 | |
Dec 01, 2020 | - | - | 2742 |
Team profile of Carpere Capital Management
Carpere Capital Management has a team of 1 member. Carpere Capital Management's team does not sit on the board of any company as of now.Co-investors of Carpere Capital Management
Over the past 6 years, 6 investors have co-invested in Carpere Capital Management's portfolio companies. This includes only funds.
- Top Co-investors of Carpere Capital Management: 6 investors entered a company along with Carpere Capital Management. These include investors like Lallemand (1 company).
